Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris
Recruiting now
Conditions studied: Psoriasis Vulgaris
In brief
Psoriasis is a common immune-mediated inflammatory skin disease affecting at least 100 million individuals worldwide. In Egypt, the prevalence of psoriasis ranges between 0.19% and 3% of the Egyptian people. It is associated with poor quality of life, reduced life expectancy and multimorbidity including psoriatic arthritis, obesity and cardiovascular disease. Vaspin (VASP, SERPIN 12) is a recently discovered adipokine that has been isolated from the visceral adipose tissue of a rat model of type 2 diabetes. It is coded by the gene SERPNA12 located on the long arm of chromosome 14q32.13 and consists of six exons and five introns.
Key facts
- Study ID
- NCT07320872
- Run by
- Aswan University
- People needed
- 60
- Starts
- 2025-08-10
- Expected to finish
- 2026-08-20
- Last updated by the study team
- 2026-01-06
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Newly diagnosed cases or stopped treatment of at least 6 months of psoriasis patients.
- Pateints with any age and gender.
You may not qualify if…
- Pregnancy and lactation.
- Patients with chronic diseases: cardiac diseases, hepatic disorders, chronic renal failure or malignancies.
- Patients with associated inflammatory disease such as infections and autoimmune diseases.
Where it is running
- Aswan University Hospital — Aswān, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.